Response to Kraut
Overview
Overview
Journal
J Natl Cancer Inst
Publisher
Oxford University Press
Specialty
Oncology
Date
2022 Nov 4
PMID
36331349
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Bartholomew T, Colleoni M, Schmidt H
. Financial incentives for breast cancer screening undermine informed choice. BMJ. 2022; 376:e065726.
DOI: 10.1136/bmj-2021-065726.
View
2.
Thornton H
. Pairing accountability with responsibility--the consequences of screening 'promotion'. Med Sci Monit. 2001; 7(3):531-3.
View
3.
Riganti P, Ruiz Yanzi M, Escobar Liquitay C, Sgarbossa N, Alarcon-Ruiz C, Kopitowski K
. Shared decision-making for supporting women's decisions about breast cancer screening. Cochrane Database Syst Rev. 2024; 5:CD013822.
PMC: 11082933.
DOI: 10.1002/14651858.CD013822.pub2.
View
4.
Kraut R
. RE: Informing women about overdetection in breast cancer screening: Two-year outcomes from a randomized trial. J Natl Cancer Inst. 2022; 115(1):112-113.
PMC: 9830472.
DOI: 10.1093/jnci/djac200.
View
5.
Pickles K, Hersch J, Nickel B, Vaidya J, McCaffery K, Barratt A
. Effects of awareness of breast cancer overdiagnosis among women with screen-detected or incidentally found breast cancer: a qualitative interview study. BMJ Open. 2022; 12(6):e061211.
PMC: 9185559.
DOI: 10.1136/bmjopen-2022-061211.
View